US Edition
Revenue growth of 22% on a constant currency basis to £14.6 million in H1 2025 representing a 3-year CAGR of 25% - Belfast Chamber
Summary by Belfast Chamber
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Revenue growth of 22% on a constant currency basis to £14.6 million in H1 2025 representing a 3-year CAGR of 25% - Belfast Chamber
Diaceutics is pleased to report another period of strong organic growth, platform adoption, and focused commercial execution. These results reflect the strength of our model and our commitment to delivering value for customers across the precision medicine landscape. Read the full update here: https://lnkd.in/ebxKkbmt Key Highlights: • Revenue growth of 22% on a constant currency […] The post Revenue growth of 22% on a constant currency basis to…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
